[1] Jemal A,Bray F,Center MM,et al. Global cancer statistics[J]. CA Cancer J Clin,2011,61(2):69-90.DOI:10.3322/caac.20107. [2] 贺捷,陈万青.2012中国肿瘤登记年报 [M].北京:军事医学科学出版社,2012. [3] Al-Batran SE,Hartmann JT,Probst S,et al. Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil,leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie[J]. J Clin Oncol,2008,26(9):1435-1442. DOI:10.1200/JCO.2007.13.9378. [4] Van Cutsem E,Moiseyenko VM,Tjulandin S,et al. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group[J]. J Clin Oncol,2006,24(31):4991-4997.DOI:10.1200/JCO.2006.06.8429. [5] Koizumi W,Narahara H,Hara T,et al.S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer(SPIRITS trial): a phase III trial[J].Lancet Oncol,2008,9(3):215-221.DOI:10.1016/S1470-2045(08)70035-4. [6] Ajani JA,Rodriguez W,Bodoky G,et al. Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial[J].J Clin Oncol,2010,28(9):1547-1553.DOI:10.1200/JCO.2009.25.4706. [7] MacDonald JS,Smalley SR,Benedetti J,et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction[J]. N Engl J Med,2001,345(10):725-730.DOI:10.1056/NEJMoa010187. [8] Smalley SR,Benedetti JK,Haller DG,et al. Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection[J]. J Clin Oncol,2012,30(19):2327-2333. [9] National comprehensive cancer network(NCCN). NCCN Guidelines in Oncolog.Gastric Cancer.Version 2.2013[S]. Washington:NCCN,2013. [10] Zhang Z,Gu X,Yin W,et al.Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia-Report on 370 patients[J]. Int J Radiat Oncol Biol Phys,1998,42(5):929-934. [11] Fiorica F,Cartei F,Enea M,et al. The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data. Cancer Treat Rev,2007,33:729-740.DOI:10.1016/j.ctrv.2007.08.005. [12] Gérard JP,Conroy T,Bonnetain F,et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203[J]. J Clin Oncol,2006,24(28):4620-4625.DOI:10.1200/JCO.2006.06.7629. [13] Bosset JF,Calais G,Mineur L,et al. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results—EORTC 22921[J]. J Clin Oncol,2005,23(24):5620-5627.DOI:10.1200/JCO.2005.02.113. [14] Cooper JS,Guo MD,Herskovic A,et al.Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial(RTOG 85-01). Radiation Therapy Oncology Group[J].JAMA,1999,281(17):1623-1627. [15] Urba SG,Orringer MB,Turrisi A,et al.Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma[J].J Clin Oncol,2001,19(2):305-313. [16] Lowy AM,Feig BW,Janjan N,et al. A pilot study of preoperative chemoradiotherapy for resectable gastric cancer[J]. Ann Surg Oncol,2001,8(6):519-524. [17] Ajani JA,Mansfield PF,Janjan N,et al.Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially respectable gastric carcinoma[J]. J Clin Oncol,2004,22(14):2774-2780. [18] Ajani JA,Walsh G,Komaki R,et al.Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction[J]. Cancer,2004,100(11):2347-2354. [19] Ajani JA,Mansfield PF,Crane CH,et al.Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome[J].J Clin Oncol,2005,23(6):1237-1244. [20] Ajani JA,Kathryn W,Okawara GS,et al.Phase Ⅱ treal of preoperative chemoradiation in patients with localized gastric adenocarcinoma(RTOG 9904):quality of combined modality therapy and pathologic response[J]. J Clin Oncol,2006,24(24):3953-3958. [21] Shridhar R,Dombi GW,Weber J,et al. Adjuvant radiation therapy increases overall survival in node-positive gastric cancer patients with aggressive surgical resection and lymph node dissection: a SEER database analysis[J]. Am J Clin Oncol,2012,35(3):216-221.DOI:10.1097/COC.0b013e31820 dbf08. [22] Shridhar R,Dombi GW,Finkelstein SE,et al. Improved survival in patients with lymph node-positive gastric cancer who received preoperative radiation: an analysis of the surveillance,epidemiology,and end results database[J]. Cancer,2011,117(17):3908-3016.DOI:10.1002/cncr.25995. [23] van Hagen P,Hulshof MC,van Lanschot JJ,et al. Preoperative chemoradiotherapy for esophageal or junctional cancer[J]. N Engl J Med,2012,366(22):2074-2084.DOI:10.1056/NEJMoa1112088. [24] Stahl M,Walz MK,Stuschke M,et al. Phase Ⅲ comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction[J]. J Clin Oncol,2009,27(6):851-856.DOI:10.1200/JCO.2008.17.0506. [25] Cuschieri A,Fayers P,Fielding J,et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial.The Surgical Cooperative Group[J]. Lancet,1996,347(9007):995-999. [26] Yonemura Y,Wu CC,Fukushima N,et al. Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: a prospective randomized trial conducted by Asian Surgeons[J]. Hepatogastroenterology,2006,53(69):389-394. [27] 詹庆友,李威,孙晓卫,等. 胃癌外科治疗的远期疗效研究 [J].中华外科杂志,2005,43(17):1109-1113. [28] Bonenkamp JJ,Songun I,Hermans J,et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients[J]. Lancet,1995,345(8952):745-748. [29] Degiuli M,Sasako M,Calgaro M,et al. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian gastric cancer study group(IGCSG) randomised surgical trial[J]. Eur J Surg Oncol,2004,30(3):303-308. [30] Fujitani K,Ajani JA,Crane CH,et al.Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastroesophageal junction[J]. Ann Surg Oncol,2007,14(4):1305-1311.DOI:10.1245/s10434-006-9198-2.
2015, Vol. 24 
